You are here

Humira

As biosimilars gain steam, Amgen exec lays out its Humira copycat plans

Fierce Pharma

Wed, 06/22/22 - 06:57 pm

More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy

Fierce Pharma

Mon, 06/20/22 - 10:37 am

autoimmune disease

Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts

Fierce Pharma

Wed, 06/1/22 - 10:15 am

Abbvie to become the biggest of pharmas in 2028

EP Vantage

Mon, 05/30/22 - 10:13 am

Bristol Myers Squibb

The patent winter is coming

EP Vantage

Wed, 05/25/22 - 10:41 am

Bristol Myers Squibb

AbbVie faces yet another 'white-coat' lawsuit claiming it used kickbacks to help promote Humira

Fierce Pharma

Sun, 05/22/22 - 09:10 pm

AbbVie's Q1 Good News That Investors Could Be Missing

Motley Fool

Sat, 04/30/22 - 02:31 pm

Five things to watch as the Biosimilars market heats up in 2022

Pharmaforum

Fri, 04/1/22 - 10:40 am

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

Fierce Pharma

Wed, 03/9/22 - 10:46 am

Organon CEO pins high hopes on upcoming Humira biosimilar launch

Fierce Pharma

Thu, 02/17/22 - 11:18 pm

Former Scripps and Humira Leader Richard Lerner Passes Away

BioSpace

Tue, 12/7/21 - 11:39 pm

Scripps Research Institute

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Fierce Pharma

Tue, 12/7/21 - 11:07 am

ICER: Unsubstantiated drug price increases cost US $1.67B in 2020, but overall net increases lower than years past

Endpoints

Tue, 11/16/21 - 10:35 am

Merck's Keytruda close to becoming top-selling drug in the world

Beckers Hospital Review

Mon, 11/1/21 - 10:39 am

Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst

Fierce Pharma

Tue, 10/19/21 - 11:59 am

Boehringer Ingelheim

interchangeable biosimilars

Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat

BioPharma Dive

Mon, 10/18/21 - 10:55 pm

Boehringer Ingelheim

interchangeable biosimilars

Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year

Fierce Pharma

Fri, 10/8/21 - 10:32 am

AbbVie's post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says

Fierce Pharma

Sat, 07/31/21 - 10:07 pm

Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst

Fierce Pharma

Tue, 07/13/21 - 11:02 am

The top 15 blockbuster patent expirations coming this decade

Fierce Pharma

Mon, 07/12/21 - 11:08 am

Pages